MentionFox
Home › IPO filings › Agriculture, latest filing in 2026
IPO filings

Agriculture, latest filing in 2026

2 companies in the IPO pipeline, every filing linked: GEBE Environmental Technology Ltd IPO, Inspire Veterinary Partners, Inc. IPO. Each section is the company's full record from its filings, newest filings first within each section.

2 companies in the IPO pipeline on this page (Agriculture, latest filing in 2026), each linked to its filing, starting with GEBE Environmental Technology Ltd IPO, Inspire Veterinary Partners, Inc. IPO. Free check on any of them: https://mentionfox.com/check

On this page

GEBE Environmental Technology Ltd IPO

StatusWithdrawn
TickerGEBE
ExchangeNasdaq Capital Market
First filed2025-06-13
Filings6

GEBE Environmental Technology Ltd filed a Form F-1 registration statement for an initial public offering on 2025-06-13. It has amended it 4 times. It asked for the registration statement to be withdrawn on 2026-09-18. Each fact below is quoted from the filing named with it.

We have reserved the symbol “GEBE” for purposes of listing our Ordinary Shares on the Nasdaq Capital Market and applied to list our Ordinary Shares on the Nasdaq Capital Market.From the F-1/A filed 2026-01-20
We plan to use the net proceeds we receive from this offering for the following purposes:From the F-1/A filed 2026-01-20
Our service revenue increased by approximately S$1.5 million ($1.1 million), or 35.8%, to approximately S$5.5 million ($4.3 million) for the six months ended June 30, 2025, compared to S$4.1 million ($3.0 million) for the same period in 2024.From the F-1/A filed 2026-01-20
Our net income amounted to approximately S$2.3 million ($1.8 million) and S$1.6 million ($1.2 million) for the six months ended June 30, 2025 and 2024, respectively.From the F-1/A filed 2026-01-20
Pursuant to Rule 477 under the Securities Act of 1933 (the “Act”), GEBE Environmental Technology Limited (the “Company”) respectfully requests the immediate withdrawal of its Registration Statement on Form F-1 (File No. 333-288017) initially filed with the U.S. Securities and Exchange Commission (the “Commission”) on June 13, 2025, together with all exhibits and amendments thereto (the “Registration Statement”), with such application to be approved effective as of the date hereof or at the earliest practical date thereafter.From the RW filed 2026-09-18
FiledWhat it isFiling
2025-06-13Registration statement filed (foreign issuer)F-1
2025-09-16Registration statement amended (foreign issuer)F-1/A
2025-11-06Registration statement amended (foreign issuer)F-1/A
2025-12-17Registration statement amended (foreign issuer)F-1/A
2026-01-20Registration statement amended (foreign issuer)F-1/A
2026-09-18Request to withdraw a registration (Form F-1)RW

Inspire Veterinary Partners, Inc. IPO

StatusPriced
TickerIVP
ExchangeNasdaq Capital Market
First filed2025-07-08
Filings9

Inspire Veterinary Partners, Inc. filed a Form S-1 registration statement for an initial public offering on 2025-07-08. It has amended it 3 times. It filed its final prospectus on 2024-07-09. Each fact below is quoted from the filing named with it.

DateRecordFigureOur pageSource
November 14, 2025Stake report, Schedule 13G/A, by Armistice Capital, LLC4.99% of the class5%+ stakesSource
August 14, 2025Stake report, Schedule 13G/A, by Armistice Capital, LLC9.99% of the class5%+ stakesSource
Our Common Stock is listed on the Nasdaq Capital Market under the symbol “IVP.” The last reported sale price of our Common Stock on the Nasdaq Capital Market on January 14, 2026, was $0.08 per share.From the S-1 filed 2026-01-16
We expect to use the net proceeds from this offering for general working capital.From the S-1 filed 2025-07-08
Service revenue decreased $660,620 or 7%, to $9,074,965 for the nine months ended September 30, 2025 as compared to $9,735,585 for the nine months ended September 30, 2024.From the S-1/A filed 2026-01-28
Our net loss for the twelve months ended December 31, 2024 was $14,264,261 and for the year ended December 31, 2023 was $14,792,886.From the S-1/A filed 2026-01-28
Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), Inspire Veterinary Partners, Inc., a Nevada corporation (the “Registrant”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal of the Registration Statement on Form S-1 (SEC File No. 333-288552, together with all exhibits thereto, the “Registration Statement”), filed by the Registrant on July 8, 2025 .From the RW filed 2025-07-30
FiledWhat it isFiling
2024-07-01Registration statement amendedS-1/A
2024-07-09Final prospectus filed: the offering is priced424B4
2025-07-08Registration statement filedS-1
2025-07-30Request to withdraw a registration (Form S-1)RW
2025-09-19Registration statement filedS-1
2025-10-06Registration statement filedS-1
2025-12-05Registration statement amendedS-1/A
2026-01-16Registration statement filedS-1
2026-01-28Registration statement amendedS-1/A

Where this comes from

A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.

Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.